Takeda Pharmaceutical (TAK) Enterprise Value (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Enterprise Value of -$5.8 billion for Q2 2026, down 22.11% year-over-year from -$7.4 billion in Q2 2025, and up 12.14% quarter-over-quarter from -$6.6 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Enterprise Value (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Enterprise Value history runs 10 years deep, the most recent figure standing at -$5.8 billion for Q2 2026.
- In Q2 2026, Enterprise Value fell 22.11% year-over-year to -$5.8 billion; the TTM figure through Jun 2026 stood at -$5.8 billion (down 22.11% YoY), while the FY2026 annual figure was -$6.9 billion, down 158.5% from the prior year.
- Enterprise Value for Q2 2026 stood at -$5.8 billion, up from -$6.6 billion in the prior quarter.
- The five-year high for Enterprise Value was -$2.7 billion in Q1 2025, with the low at -$8.2 billion in Q3 2022.
- The 5-year median for Enterprise Value is -$6.2 billion (2026), against an average of -$5.8 billion.
- The sharpest annual moves came in 2023 and 2026: Enterprise Value surged 46.46% in 2023, then slumped 148.51% in 2026.
- Takeda Pharmaceutical's Enterprise Value stood at -$6.8 billion in 2022, then surged by 44.5% to -$3.8 billion in 2023, then tumbled by 55.4% to -$5.9 billion in 2024, then fell by 19.53% to -$7.0 billion in 2025, then grew by 17.3% to -$5.8 billion in 2026.
- Business Quant data shows TAK's Enterprise Value at -$5.8 billion in Q2 2026, -$6.6 billion in Q1 2026, and -$7.0 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | -164.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | -656.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.79 Bn |
| Mar 31, 2026 | -6.59 Bn |
| Dec 31, 2025 | -7.00 Bn |
| Sep 30, 2025 | -7.10 Bn |
| Jun 30, 2025 | -4.74 Bn |
| Mar 31, 2025 | -2.65 Bn |
| Dec 31, 2024 | -5.86 Bn |
| Sep 30, 2024 | -7.51 Bn |
| Jun 30, 2024 | -7.47 Bn |
| Mar 31, 2024 | -3.19 Bn |
| Dec 31, 2023 | -3.77 Bn |
| Sep 30, 2023 | -4.37 Bn |
| Jun 30, 2023 | -4.44 Bn |
| Mar 31, 2023 | -4.18 Bn |
| Dec 31, 2022 | -6.79 Bn |
| Sep 30, 2022 | -8.16 Bn |
| Jun 30, 2022 | -7.19 Bn |
| Mar 31, 2022 | -7.52 Bn |
| Dec 31, 2021 | -8.39 Bn |
| Sep 30, 2021 | -7.67 Bn |